The yellow wing pigment of the swallowtail but terfly, Papilio xuthus, is composed of two groups of compounds. The main pigment, Papiliochrome II, has been investigated since 1954 by Umebachi [1] and some of the physical and chemical properties have already been reported [2 ] . Remarkably enough, it neither belongs to the class of pterins nor to the ommochromes, both of which are com mon insect pigments. Papiliochrome II is very labile and is readily decomposed to L-kynurenine and the DOPAmine derivative SN-1 by weak mineral acid already. By hydrolysis in I n HCI at 100 °C for two hours [3, 4 ] , SN-1 is further broken down into /5-alanine and the DOPAmine derivative SN-1 a. SN-1 has been presumed to be a N-(/9-alanyl) DOPAmine derivative. These results are supported by 14C-incorporation of the injected precursors [ 14C] tryptophan, [ 14C] DOPAmine, and [ 14C]/?-alanine into the yellow wing pigments [2, 3, 5] .
Umebachi suggested that Papiliochrome II might be a molecular complex of kynurenine and SN-1. Our first step for structural elucidation was there fore to analyse this DOPAmine derivative. The present paper reports the identification of the DOPAmine moiety as noradrenaline, the elucida tion of SN-1 as N-(/?-alanyl) -noradrenaline, and the synthesis of this peptide. 
Material and Methods
All chemicals used were of analytical grade. SN-1 was prepared from wings of male adults of P. xuthus as described already [4 ] .
Derivatives of SN-1 were prepared in the fol lowing way: About 0.1 mg of SN-1 was sealed in a small glass ampoule together with 5 -10 //I N,0-bis-(trimethylsilyl)-acetamide (BSA) or the deuterated compound under nitrogen and heated at 200 °C for 5 min. For mass spectrometric analysis a direct inlet system with a temperature program between 20 -300 C was used. The TMS derivative evaporated at 220 C. For preparation of the TFA derivative, about 0.1 mg of SN-1 was sealed with 5 -10 /j\ trifluoroacetic acid anhydride and a trace of 3-(dimethylamino-) pyridine under nitrogen and kept at 150 C for 5 min. This derivative too was directly introduced into the mass spectrometer; evaporation temperature 220 °C. For hydrolysis, about 1 mg of SN-1 in 1 ml 3 N HCI was kept under nitrogen in a sealed ampoule for 1 hour at 100 °C. The acid was then evaporated under reduced pressure, 100 ju\ BSA were added, and the mixture was heated under nitrogen for 10 min at 200 °C. The reaction mixture was analysed in a capillary GC-MS-system. A CH7 A-MAT mass spectrometer coupled with a glass capillary column SE-30 (LKB, 25 m length, 0.35 mm i.d., He flux 0.5 cm3 per min), and con nected with a computer SS-100MAT, was used. The glass capillary was heated in a linear program from 100 -325 °C with a temperature rate of 10 °C/min. Spectra were measured with 70 EV, emission 1 mA, ion source temperature 250 °C.
NMR spectra were measured with a Bruker WH90 Fourier instrument, solvent D20/Me0H-D4/DCl, TMS as internal standard.
N-Hydroxysuccinimide ester of benzyloxycarbonyl-ß-alanine ( I )
Benzyloxycarbonyl-/?-alanine (17.85 g, 80 mmol) and hydroxysuccinimide (9.20 g, 80 mmol) were dissolved in 300 ml of anhydrous tetrahydrofuran. The solution was cooled to 4 °C, an icecold solution of dicyclohexylcarbodiimide (18.15 g, 80 mmol + 10%) in anhydrous tetrahydrofuran was added, and the mixture was stirred at 4 °C for a period of 48 h. The dicyclohexyl-urea which had formed was removed by filtration and washed with tetrahydro furan. The filtrate was evaporated to dryness to yield a yellow oil. Recrystallization from isopropanol yielded 23.45 g of white crystals (91%). Apart from the well-known decomposition of Nhydroxysuccinimide esters on silica-gel [6 ] , the compound was pure according to TLC in ether, tetrahydrofuran and isopropanol. M.P. 83° -84 °C. NMR (Acetone-D6/D20/DCl) : < 3 2.92 (methylene groups of hydroxysuccinimide), 2.94 and 3.55 (me thylene groups of ^-alanine), 5.21 (methylene group of Z-residue), 7.37 (aromatic protons).
Anal 
N -( Benzyloxy carbonyl-ß-alanyl) -L-nor adrenaline
(ID L-Noradrenaline (1.69 g, 10 mmol) was suspend ed in 35 ml of dimethylformamide, and 1.1ml (10 mmol) N-methylmorpholine together with a solu tion of benzyloxycarbonyl-/?-alanine-hydroxysuccinimide ester (3.84 g, 12 mmol) in another 35 ml of dimethylformamide was added. In order to minimize autoxidation, the solvent used was previ ously flushed with hydrogen and the reaction vessel was closed under hydrogen. After stirring for 48 h in the cold, a clear solution had formed. 2-(l-Piperazinyl-)ethylamine [7 ] (0.52 ml, 0.4 equiv.) was added and the solution was allowed to adjust to room temperature for 1 h. The solvent was removed in a rotary evaporator under vacuum; ethyl acetate (100 ml) and 0.5 N H2S04 (50 ml) were added. Following shaking and separation, the aqueous layer was extracted four times with 20 ml of ethyl acetate. The ethyl acetate phases were combined and the resulting solution was washed 3 times with saturated sodium chloride solution. After drying over anhydrous sodium sulfate, evaporation of the ethyl acetate left 3.61 g of a colourless oil (96% yield) which soon crystallized. Recrystallization from 130 ml of ethyl acetate gave 3.07 g (82%) of a white product. A second crystallization from MeOHHoO ( 1 : 9 ) yielded 2.58 g of white needles which were found fo be pure according to TLC in n-butanol/HOAc/HoO ( 6 : 2 : 2 ) . M.P. 124 -1 2 5 °C. NMR (Acetone-D6/D20 ) : ö 2.44 and 3.40 (me thylene groups of /?-alanine), 3.38 (methylene group of noradrenaline), 4.61 (methine group of nor adrenaline), 5.07 (methylene group of Z-residue), 6 .75 (aromatic protons of noradrenaline), 7.40 (aromatic protons of Z-residue).
Anal. Calcd. for C19H22N 20 6: C, 60.95; H, 5.92; N, 7.48. Found: C, 6 0 .9 6 ;^, 5.90; N, 7.48.
N -ß-alanyl-L-noradrenaline ( 111)
Z-/?-alanyl-L-noradrenaline (1.2 g, 3.2 mmol) was dissolved in 70 ml of Me0H-H20 ( 4 : 1 ) , the solu tion was flushed with N 2 for 10 min and palladium blade was added as a catalyst. The suspension was stirred magnetically, while a stream of hydrogen gas was passed into it at room temperature. After 24 h, no starting material could be detected by TLC in n-butanol/H0Ac/H20 ( 6 : 2 : 2 ) . The catalyst was removed by filtration, 100 ml of water were added and the methanol was removed in a rotary evaporator. The remaining aqueous solution was lyophilized, yielding 0.75 g (97.5%) of III which was found to be homogeneous according to TLC in the above mentioned system. The substance is hygro scopic. M .P. 
Results and Discussion

Structure of SN-1
Papiliochrome II and its SN-1 component can be collected from wings in small amounts only. Struc tural elucidation of SN-1 as N-(/?-alanyl) -noradre naline was achieved by a combination of nuclear magnetic resonance and mass spectroscopic data.
The 3.4-dihydroxyphenyl (catechol) nucleus of the molecule is confirmed primarily through the aromatic protons (multiplet at 6.80 ppm) displayed in the nuclear magnetic resonance data of SN-1 (Table) . The other upfield signals of the alkyl sub stituent can be identified in combination with the mass spectra of the derivatives penta-(trimethylsilyl)-SN-l and tetra-(trifluoroacetyl)-SN-l.
The molecular ion peak of the TMS derivative (Fig. 1) is at m/e 600. By comparison with the deuterated D9-derivative, molecular weight 645, one counts five TMS reactive groups and a molecular weight of 240 for SN-1. The most prominent ion from the TMS derivative is at m/e 355, and from the Dg-TMS derivative at m/e 382. These ions fit into the structure of a 1-hydroxymethylenecatechol tris(trimethylsilyl ether) cation and therefore point towards the /?-hydroxyl group contained in nor adrenaline. Such a structure is supported by the further mass fragmentation pattern, by the A 2B system of the protons at position 4 and 5 in the nuclear magnetic resonance spectrum (Table) , and finally confirmed by comparison with the mass spectrum of synthetic TMS-noradrenaline. Combina tion of these facts proves identity of SN-la with noradrenaline. The linkage of noradrenaline with /?-alanine (A 2B2 system of the protons at position 1 and 2, Table) is shown by the McLafferty fragment at m/e 368 for the TMS (Fig. 1) , and at m/e 395 for the Dn-TMS derivative of SN-1. The corre- Table. sponding fragment represents the ion at m/e 440 in the mass spectrum of tetra-(trifluoroacetyl-) SN-1 (Fig. 2) . All further MS studies equally confirm the structure of SN-1 as N-(/?-alanyl-)noradrenaline.
The products from hydrolysis of SN-1 in I n HC1, 100 °C, were separated as TMS derivatives in a capillary gas chromatograph coupled with the mass spectrometer.
Only tris (trimethylsilyl)/>-alanine (Fig. 3, peak I ) and penta (trimethylsilyl)-noradre naline (Fig. 3, peak II) 
Synthesis of N -(ß -a la n yl)-L-n oradrenaline, SN-1
The synthesis of this compound which has some structural similarity with a peptide, was performed in the following sequence: For the acylation of noradrenaline by the amino acid /5-alanine, the general principles of peptide syn thesis, namely protection of the amino group and activation of the carboxyl function, had to be ap plied. The well known tendency of catecholamines towards autoxidation suggested the use of the benzyloxycarbonyl-group (Z) to protect the aminogroup of ^-alanine, as this residue may be removed by hydrogenation. Problems might arise from a pos sible nucleophilic attack on the three hydroxyl groups in the noradrenaline molecule. In combina tion, however, with suitable activation methods, amino acids with non-protected hydroxyl functions in the side chain have previously been used in pep tide synthesis: Inouye et al. [8] describe the cou pling of Z-/?-alanine with tyrosine methyl ester with unmasked oxygen function; a series of peptides containing 3,4-dihydroxyphenylalanine (DOPA) was successfully prepared without protection of the phenolic hydroxyl groups (Losse et al. [9 ] , O'Neill et al. [1 0 ] ). N-Hydroxysuccinimide esters were introduced into peptide synthesis by Anderson et al. [11, 12] . Their high reactivity with aminogroups as compared to a rather modest sensitivity against hydrolysis and alcoholysis [13] prompted us to choose this method of activation for the desired acylation of the primary amino group of L-noradrenaline in the presence of two phenolic and one ali phatic non-protected hydroxyl groups. The N-hydroxysuccinimide ester of benzyloxycarbonyl-/?-
